Today's top #BusinessModel report is on Life Sciences rebrand.ly/fcd14xk Get our free reports on geography of your interest to your mailbox regularly https://rb.gy/cx2upn

1. TRACXN TOP BUSINESS MODELS REPORT
March 09, 2022
LIFE SCIENCES

2. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Contents
Life Sciences Funding Overview 3
Top Funded Business Models 4
One Pagers 9
Appendix 59
2

3. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Funding in last 1 year
3
Oncology $16.3B
Genomics $14.5B
Life Sciences Platforms and Tools $9.9B
Life Sciences Tech $8.8B
Neurology $5.2B
Immunology $4.5B
Y-o-Y Funding
Top Investors by Funding Rounds
Seed
Stage
Y Combinator
SOSV
Khosla Ventures
29
8
5
Early
Stage
Alexandria
RA Capital Management
Orbimed
33
31
29
Late
Stage
RA Capital Management
Fidelity Investments
Orbimed
15
14
12
Funding by Geography
Top Feeds by $ Funding
Top Funding Rounds
United States (65%)
China (10%)
United Kingdom (8%)
France (2%)
Switzerland (2%)
Germany (2%)
Denmark (2%)
Others (11%)
$ Funding # Rounds
Caris Life Sciences
(1996, United States)
$830M - Series D
AboGen
(2012, United States)
$700M - Series A
CMR Surgical
(2014, United Kingdom)
$600M - Series D
LEO Pharma
(1908, Denmark)
$537M - PE
ElevateBio
(2018, United States)
$525M - Series C
Eikon
(2019, United States)
$518M - Series B
Neumora
(2020, United States)
$500M - Series A
Laronde
(2017, United States)
$440M - Series B
Pivot Bio
(2010, United States)
$430M - Series D
XtalPi
(2014, United States)
$400M - Series D
Insitro
(2018, United States)
$400M - Series C
Adagio
(2020, United States)
$336M - Series C

4. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (1/5)
4
Rank Business Model $ Funding # Rounds Top Funding Round Details
1<> 0 Drugs for Multiple Cancer Types $9.2B 264 Sotio | $317M | Series D Link
2<> 0 Life Sciences Research Services $3.2B 99 Immunai | $215M | Series B Link
3<> 0 Gene Therapy Drugs $1.8B 51 Wugen | $172M | Series B Link
4▲1 Cheminformatics Software $1.7B 28 XtalPi | $400M | Series D Link
5▲1 Neurological Disorder Drugs $1.7B 43 Neumora | $500M | Series A Link
6▲13 Sequencing-based Genomic Precision Medicine $1.5B 30 Caris Life Sc.. | $830M | Series D Link
7▲11 Neurodegenerative Disorders Drugs $1.5B 38 Sonoma Biothe.. | $265M | Series B Link
8▲2 Autoimmune Disorders Drugs $1.4B 25 Sonoma Biothe.. | $265M | Series B Link
9▲15 Robot Assisted Surgery $1.3B 23 CMR Surgical | $600M | Series D Link
10▲7 Hematologic Cancer Drugs $1.1B 14 ElevateBio | $525M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

5. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (2/5)
5
Rank Business Model $ Funding # Rounds Top Funding Round Details
11▲1 Gene Editing Platforms $1.1B 23 Prime Medicine | $200M | Series B Link
12▼5 Cancer Diagnostic Tests $1.0B 11 Freenome | $300M | Series D Link
13▲2 Genomic Biomarker Discovery Research $857M 5 Freenome | $300M | Series D Link
14▲24 Genomic Sequencing Instruments $780M 12 Element Biosc.. | $276M | Series C Link
15▲153 Biopreservation Devices $775M 4 AboGen | $700M | Series A Link
16▼12 Pan-Cancer Drugs $769M 20 Hummingbird B.. | $125M | Series C Link
17▼8 Genomic Data Analysis Platforms $752M 14 Insilico | $255M | Series C Link
18▲35 Genomics Sequencing Analysis Software $714M 14 Element Biosc.. | $276M | Series C Link
19▲24 Proteomics Drug Discovery Software $684M 11 Eikon | $518M | Series B Link
20<> 0 Diversified $678M 19 CinCor | $143M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

6. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (3/5)
6
Rank Business Model $ Funding # Rounds Top Funding Round Details
21▲15 Genomics Drug Discovery Software $621M 8 Insilico | $255M | Series C Link
22▲33 COVID-19 Drugs $617M 12 Adagio | $336M | Series C Link
23▼7 Inflammatory Diseases Drugs $610M 14 Apollo Therap.. | $145M | Series A Link
24▲57 Clinical Trial Patient Recruitment Platforms $595M 10 Reify Health | $220M | Series C Link
25▲1 Diabetes Drugs $553M 16 Jaguar Gene T.. | $139M | Series B Link
26▲11 Synthetic Biology $553M 9 Pivot Bio | $430M | Series D Link
27▼19 DNA Liquid Biopsy Diagnostics $551M 14 Jiyinga Techn.. | $116M | Series C Link
28▲7 Nucleic Acid Sequencing Equipment $504M 11 Nanopore | $271M | Series H Link
29▲18 Gene Delivery Platforms $452M 11 Synthego | $200M | Series E Link
30▼9 Agrigenomics $448M 19 Inari | $208M | Series D Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

7. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (4/5)
7
Rank Business Model $ Funding # Rounds Top Funding Round Details
31▼2 Genomics Research Services $426M 27 Kallyope | $236M | Series D Link
32▼21 Retinal Disorders Drugs $425M 16 Vedere | $77.0M | Series A Link
33▲53 Decentralized Clinical Trial Management $418M 4 Medable | $304M | Series D Link
34▲184 Cancer Precision Medicine Diagnostic Tests $418M 14 ITM | $109M | Series D Link
35▲16 Ophthalmology Drugs $398M 33 Gyroscope | $148M | Series C Link
36▲64 Radioisotopes for Imaging $374M 8 SHINE Medical.. | $150M | Series C Link
37▼24 RNA Interference Platforms $362M 4 Siwei Biotech.. | $188M | Series B Link
38▲93 Lung Infection Drugs $355M 8 HilleVax | $135M | Series D Link
39▲11 Metabolic Disorders Drugs $351M 26 Jaguar Gene T.. | $139M | Series B Link
40▲81 Life Science R&D Workflow Management Software $335M 8 Benchling | $200M | Series E Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

8. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (5/5)
8
Rank Business Model $ Funding # Rounds Top Funding Round Details
41▲39 Genome Sequence Analysis Software $330M 9 DNAnexus | $200M | Series G Link
42▲246 Intravenous Drug Delivery Systems $326M 7 Enable Inject.. | $215M | Series C Link
43▲112 Chemoproteomics Software $301M 6 Seismic | $101M | Series A Link
44▲40 Renal Disorders Drugs $300M 9 Ceptur Thera.. | $75.0M | Series A Link
45▲28 Wound Healing Drugs $299M 9 Endeavor Biom.. | $101M | Series B Link
46▲33 Ultrasound Imaging Devices $286M 5 Exo | $220M | Series C Link
47▼20 At-Home Preventive Genetic Test Kits $284M 10 Variant Bio | $105M | Series B Link
48▲100 Aesthetic Medicines $284M 7 Dermavant | $160M | Series D Link
49▲48 Nucleic Acid Synthesis Instruments $284M 5 DNA Script | $200M | Series C Link
50▲11 Nanoparticle Based Drug Delivery Systems $281M 12 Siwei Biotech.. | $188M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

9. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sotio (2010, Czech Republic)
$317M - Series D - Dec 2021
Exscientia (2012, United Kingdom)
$225M - Series D - Apr 2021
Umoja Biopharma (2019, United States)
$210M - Series B - Jun 2021
Vaccitech (2016, United Kingdom)
$168M - Series B - Mar 2021
NMS Group (1965, Italy)
$158M - Series D - Jan 2022
Artios Pharma (2015, United Kingdom)
$153M - Series C - Jul 2021
Shoreline Bio.. (2020, United States)
$140M - Series B - Nov 2021
View all 264 Funding Rounds on Tracxn Platform
Drugs for Multiple Cancer Types
01
9
Back to index
Oncology (Guardant Health)
(# Cos: 4569 | $103B)
Drugs (Moderna)
(# Cos: 2948 | $79.0B)
Diversified (Exscientia)
(# Cos: 2354 | $63.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$9.2B (▼23.9%)
264(▼9.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
195
$63.4B
1681
379
2354
269
Exscientia
(2012, United Kingdom, $429M)
Moderna
(2010, United States, $2.8B)
BeiGene
(2010, United States, $172M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

10. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Immunai (2018, United States)
$215M - Series B - Oct 2021
Arbor Biotech.. (2016, United States)
$215M - Series B - Nov 2021
Synthego (2012, United States)
$200M - Series E - Feb 2022
Wugen (2018, United States)
$172M - Series B - Jul 2021
Mammoth (2017, United States)
$150M - Series D - Sep 2021
Dewpoint Ther.. (2018, United States)
$150M - Series C - Feb 2022
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
View all 99 Funding Rounds on Tracxn Platform
Life Sciences Research Services
02
10
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9829 | $52.2B)
Research Services (Ancestry)
(# Cos: 5007 | $30.6B)
Diversified (Ginkgo Bioworks)
(# Cos: 3365 | $24.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$3.2B (▲2.4%)
99(▼39.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
313
$24.3B
1835
182
3365
158
Ginkgo Bioworks
(2009, United States, $796M)
Human Longevity
(2013, United States, $330M)
Amyris
(2003, United States, $487M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

11. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Therapy Drugs
03
11
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.8B (▼30.2%)
51(▼26.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
58
$13.2B
384
83
556
74
Genomics (Ginkgo Bioworks)
(# Cos: 7650 | $83.7B)
Applied Genomics (MyHeritage)
(# Cos: 4162 | $54.5B)
Clinical Genomics (Guardant Health)
(# Cos: 2224 | $40.9B)
Therapeutics (Alnylam)
(# Cos: 556 | $13.2B)
Alnylam
(2002, United States, $17.0M)
Roche
(1896, Switzerland)
Spark Therapeutics
(2013, United States, $82.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Wugen (2018, United States)
$172M - Series B - Jul 2021
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Forge Biologics (2020, United States)
$120M - Series B - Apr 2021
Ring Therapeu.. (2018, United States)
$117M - Series B - Jul 2021
Sirnaomics (2007, United States)
$105M - Series E - Jul 2021
Dyno Therapeu.. (2018, United States)
$100M - Series A - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
View all 51 Funding Rounds on Tracxn Platform

12. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cheminformatics Software
04
12
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.7B (▼1.4%)
28(▼3.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
22
$4.9B
150
7
305
26
Life Sciences Tech (Illumina)
(# Cos: 4920 | $27.4B)
Research & Development (Medidata)
(# Cos: 3970 | $22.9B)
Drug Discovery (Human Longevity)
(# Cos: 1197 | $12.2B)
Cheminformatics (Exscientia)
(# Cos: 305 | $4.9B)
Exscientia
(2012, United Kingdom, $429M)
ATAI
(2018, Germany, $387M)
Schrodinger
(1990, United States, $162M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
XtalPi (2014, United States)
$400M - Series D - Aug 2021
Insitro (2018, United States)
$400M - Series C - Mar 2021
Exscientia (2012, United Kingdom)
$225M - Series D - Apr 2021
InterVenn (2017, United States)
$201M - Series C - Aug 2021
Owkin (2016, France)
$180M - Series B - Nov 2021
HotSpot Thera.. (2017, United States)
$100M - Series C - Nov 2021
METiS (2021, United States)
$86.0M - Series A - Dec 2021
View all 28 Funding Rounds on Tracxn Platform

13. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Neumora (2020, United States)
$500M - Series A - Oct 2021
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
Septerna (2020, United States)
$100M - Series A - Jan 2022
Vigil (2020, United States)
$90.0M - Series B - Aug 2021
Flare Therape.. (2021, United States)
$82.0M - Series A - May 2021
Beckley Psyt.. (1998, United Kingdom)
$80.0M - Series B - Aug 2021
Ceptur Therap.. (2021, United States)
$75.0M - Series A - Jan 2022
View all 43 Funding Rounds on Tracxn Platform
Neurological Disorder Drugs
05
13
Back to index
Neurology (MindMaze)
(# Cos: 2614 | $31.9B)
Drugs (Biogen)
(# Cos: 1397 | $24.6B)
Diversified (Jazz Pharmaceuticals)
(# Cos: 345 | $7.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.7B (▲23.6%)
43(▼10.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
33
$7.2B
246
58
345
40
Jazz Pharmaceuticals
(2003, Ireland, $265M)
PureTech Health
(2001, United States, $107M)
Alkermes
(1987, Ireland, $46.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

14. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sequencing-based Genomic Precision
Medicine
06
14
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.5B (▲155%)
30( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
36
$12.2B
228
50
416
34
Genomics (Ginkgo Bioworks)
(# Cos: 7650 | $83.7B)
Applied Genomics (MyHeritage)
(# Cos: 4162 | $54.5B)
Clinical Genomics (Adaptive Biotechnologies)
(# Cos: 2224 | $40.9B)
Diagnostics (Natera)
(# Cos: 1631 | $27.1B)
Sequencing-based (Guardant Health)
(# Cos: 1328 | $25.1B)
Precision Medicine (Bluebird Bio)
(# Cos: 416 | $12.2B)
Bluebird Bio
(1992, United States, $136M)
Intellia Therapeutics
(2014, United States, $85.0M)
UniQure
(1998, Netherlands, $200M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Caris Life Sc.. (1996, United States)
$830M - Series D - May 2021
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
SHINE Medical.. (2010, United States)
$150M - Series C - Jun 2021
Omega Therape.. (2016, United States)
$126M - Series C - Mar 2021
BerryOncology (2017, China)
$108M - Series B - Aug 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
Bluestar Geno.. (2016, United States)
$70.0M - Series C - May 2021
View all 30 Funding Rounds on Tracxn Platform

15. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Amylyx Pharma.. (2013, United States)
$135M - Series C - Jul 2021
Skyhawk Thera.. (2017, United States)
$133M - Series B - Sep 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
LEXEO Therape.. (2018, United States)
$100M - Series B - Sep 2021
Verge Genomics (2015, United States)
$98.0M - Series B - Dec 2021
Vanqua Bio (2019, United States)
$85.0M - Series B - Sep 2021
View all 38 Funding Rounds on Tracxn Platform
Neurodegenerative Disorders Drugs
07
15
Back to index
Neurology (MindMaze)
(# Cos: 2614 | $31.9B)
Drugs (Jazz Pharmaceuticals)
(# Cos: 1397 | $24.6B)
Neurodegenerative (Biogen)
(# Cos: 514 | $9.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.5B (▲136%)
38(▼5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
32
$9.0B
356
58
514
50
Biogen
(1978, United States, $80.0M)
AskBio
(2001, United States, $235M)
PTC Therapeutics
(1998, United States, $248M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

16. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Alumis (2021, United States)
$200M - Series B - Jan 2022
BioTheryX (2007, United States)
$92.1M - Series E - May 2021
Kyverna Thera.. (2018, United States)
$85.0M - Series B - Jan 2022
ROME Therapeu.. (2020, United States)
$77.0M - Series B - Sep 2021
Interius Biot.. (2020, United States)
$76.0M - Series A - May 2021
PlateletBio (2019, United States)
$75.5M - Series B - Nov 2021
View all 25 Funding Rounds on Tracxn Platform
Autoimmune Disorders Drugs
08
16
Back to index
Immunology (Horizon Therapeutics)
(# Cos: 905 | $23.4B)
Drugs (Moderna)
(# Cos: 763 | $22.5B)
Autoimmune Diseases (Biogen)
(# Cos: 127 | $7.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.4B (▲52.8%)
25(▲4.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$7.4B
84
21
127
20
Biogen
(1978, United States, $80.0M)
Moderna
(2010, United States, $2.8B)
Horizon Therapeutics
(2008, Ireland, $61.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

17. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Robot Assisted Surgery
09
17
Back to index
Surgical Instruments (Corindus Vascular Robotics)
(# Cos: 698 | $6.9B)
Robotic Surgery (Intuitive)
(# Cos: 183 | $4.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.3B (▲171%)
23(▲21.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
20
$4.6B
113
13
183
26
Intuitive
(1995, United States, $47.0M)
Corindus Vascular Robo..
(2001, United States, $21.9M)
Hansen Medical
(2002, United States, $68.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
CMR Surgical (2014, United Kingdom)
$600M - Series D - Jun 2021
Edge Medical Robotics (2017, China)
$200M - Series C - Nov 2021
Memic Surgery (2013, Israel)
$96.0M - Series D - Apr 2021
Distalmotion (2012, Switzerland)
$90.0M - Series E - Jan 2022
PROCEPT BioRo.. (2009, United States)
$85.0M - Series G - Jun 2021
ColubrisMX (2017, United States)
$76.1M - Series C - Jun 2021
ColubrisMX (2017, United States)
$69.0M - Series B - May 2021
View all 23 Funding Rounds on Tracxn Platform

18. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
ElevateBio (2018, United States)
$525M - Series C - Mar 2021
Wugen (2018, United States)
$172M - Series B - Jul 2021
Monte Rosa Th.. (2020, United States)
$95.0M - Series C - Mar 2021
Heyuan Biotechnology (2018, China)
$64.2M - Series C - Oct 2021
Allterum (2018, United States)
$64.0M - Series A - Jan 2022
Ossium Health (2016, United States)
$63.0M - Series B - Mar 2021
Ajax (2019, United States)
$40.0M - Series C - Jun 2021
View all 14 Funding Rounds on Tracxn Platform
Hematologic Cancer Drugs
10
18
Back to index
Oncology (Guardant Health)
(# Cos: 4569 | $103B)
Drugs (Exscientia)
(# Cos: 2948 | $79.0B)
Blood Cancer (Sierra Oncology)
(# Cos: 85 | $4.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B (▲76.6%)
14(▲40%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$4.3B
66
21
85
10
Sierra Oncology
(2003, Canada, $75.0M)
ASLAN Pharmaceuticals
(2010, Singapore, $100M)
Syros Pharmaceuticals
(2012, United States, $124M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

19. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Editing Platforms
11
19
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B (▲29.1%)
23(▲35.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$2.7B
63
2
92
15
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Enabling Technologies (Illumina)
(# Cos: 1680 | $17.0B)
Technology Platforms (Twist Bioscience)
(# Cos: 358 | $8.1B)
Gene Editing (eGenesis)
(# Cos: 92 | $2.7B)
eGenesis
(2015, United States, $265M)
Locus Biosciences
(2015, United States, $32.3M)
Tessera Therapeutics
(2018, United States, $230M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Prime Medicine (2019, United States)
$200M - Series B - Jul 2021
Graphite Bio (2020, United States)
$151M - Series B - Mar 2021
Korro Bio (2018, United States)
$116M - Series B - Jan 2022
SalioGen Ther.. (2019, United States)
$115M - Series B - Dec 2021
Scribe Therap.. (2018, United States)
$100M - Series B - Mar 2021
BioHeng (2017, China)
$80.0M - Series B - Mar 2021
Qixin Biotechnology (2017, China)
$67.0M - Series A - Mar 2021
View all 23 Funding Rounds on Tracxn Platform

20. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Freenome (2014, United States)
$300M - Series D - Dec 2021
Freenome (2014, United States)
$290M - Series D - Jan 2022
PathAI (2016, United States)
$165M - Series C - May 2021
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Craif (2018, Japan)
$11.3M - Series B - Nov 2021
Travera (2017, United States)
$8.4M - Series A - Apr 2021
View all 11 Funding Rounds on Tracxn Platform
Cancer Diagnostic Tests
12
20
Back to index
Oncology (Exscientia)
(# Cos: 4569 | $103B)
In-Vitro Diagnostic Tests (Guardant Health)
(# Cos: 1150 | $18.8B)
Pan Cancer (GRAIL)
(# Cos: 194 | $6.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.0B (▼22.1%)
11(▼45%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
23
$6.1B
124
9
194
16
GRAIL
(2016, United States, $2.0B)
PathAI
(2016, United States, $255M)
Color
(2013, United States, $491M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

21. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Freenome (2014, United States)
$300M - Series D - Dec 2021
Freenome (2014, United States)
$290M - Series D - Jan 2022
Maze Therapeu.. (2018, United States)
$190M - Series C - Jan 2022
HiFiBiO (2013, France)
$75.0M - Series D - Jun 2021
Wobble Genom.. (2020, United
Kingdom)
$1.7M - Seed - Sep 2021
Genomic Biomarker Discovery Research
13
21
Back to index
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Genomics Research (Metabolon)
(# Cos: 185 | $4.6B)
Biomarker Discovery (Freenome)
(# Cos: 93 | $3.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$857M (▲29%)
5(▼58.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$3.4B
54
6
93
12
Freenome
(2014, United States, $1.1B)
Metabolon
(2000, United States, $148M)
Tango Therapeutics
(2017, United States, $165M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

22. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomic Sequencing Instruments
14
22
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$780M (▲210%)
12(▲20%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
12
$2.8B
56
5
96
10
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Enabling Technologies (Illumina)
(# Cos: 1680 | $17.0B)
Instrument Systems (10X Genomics)
(# Cos: 317 | $5.4B)
Nucleic Acid Analysis (PacBio)
(# Cos: 191 | $3.2B)
Sequencing (Nanopore)
(# Cos: 96 | $2.8B)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Purigen Biosystems
(2012, United States, $88.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series B - Jun 2021
Purigen Biosy.. (2012, United States)
$34.4M - Series C - Apr 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
View all 12 Funding Rounds on Tracxn Platform

23. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
AboGen (2012, United States)
$700M - Series A - Aug 2021
Bridge to Life (2012, United States)
$56.0M - Series A - Aug 2021
Genepoint Biological .. (2015, China)
$18.8M - Series C - Jun 2021
Genepoint Biological .. (2015, China)
Undisclosed - Series C - Jul 2021
Biopreservation Devices
15
23
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9829 | $52.2B)
Instruments (Illumina)
(# Cos: 2046 | $12.2B)
Preservation (Brooks Automation)
(# Cos: 80 | $911M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$775M (▲1225%)
4(▼50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
6
$911M
38
1
80
4
Brooks Automation
(1978, United States)
Stirling Ultracold
(2009, United States, $8.7M)
Atelerix
(2017, United Kingdom, $1.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

24. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Hummingbird Biosc.. (2015, Singapore)
$125M - Series C - May 2021
Anaveon (2017, Switzerland)
$119M - Series B - Dec 2021
Obsidian Ther.. (2015, United States)
$115M - Series B - Sep 2021
Boundless Bio (2018, United States)
$106M - Series B - Apr 2021
Elpiscience (2017, China)
$105M - Series C - May 2021
Hibercell (2015, United States)
$67.4M - Series B - May 2021
TCRCure Biopharma (2016, China)
$47.3M - Series B - Feb 2022
View all 20 Funding Rounds on Tracxn Platform
Pan-Cancer Drugs
16
24
Back to index
Oncology (Guardant Health)
(# Cos: 4569 | $103B)
Drugs (Exscientia)
(# Cos: 2948 | $79.0B)
Pan Cancer (GigaGen)
(# Cos: 342 | $7.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$769M (▼60.1%)
20(▼58.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
26
$7.6B
223
44
342
38
GigaGen
(2011, United States, $36.1M)
TScan Therapeutics
(1995, United States, $180M)
Shattuck Labs
(2016, United States, $165M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

25. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Insilico (2014, China)
$255M - Series C - Jun 2021
Benchling (2012, United States)
$200M - Series E - Apr 2021
iCarbonX (2015, China)
$151M - Series D - Apr 2021
Benchling (2012, United States)
$100M - Series F - Nov 2021
54gene (2019, Nigeria)
$25.0M - Series B - Sep 2021
Genoox (2012, Israel)
$8.0M - Series B - Jun 2021
Nostos Genomics (2018, Germany)
$5.6M - Seed - Feb 2022
View all 14 Funding Rounds on Tracxn Platform
Genomic Data Analysis Platforms
17
25
Back to index
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Genome Informatics (Benchling)
(# Cos: 737 | $5.0B)
Integrative Bioinformatics Platforms
(Human Longevity)
(# Cos: 473 | $3.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$752M (▼26.6%)
14(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
41
$3.8B
169
6
473
17
Human Longevity
(2013, United States, $330M)
Benchling
(2012, United States, $412M)
Quest Diagnostics
(1967, United States)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

26. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomics Sequencing Analysis Software
18
26
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$714M (▲260%)
14(▼30%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
54
$3.1B
200
9
526
20
Life Sciences Tech (Illumina)
(# Cos: 4920 | $27.4B)
Research & Development (Medidata)
(# Cos: 3970 | $22.9B)
Drug Discovery (Exscientia)
(# Cos: 1197 | $12.2B)
Genomics (Qiagen)
(# Cos: 730 | $5.1B)
Sequencing Analysis (Human Longevity)
(# Cos: 526 | $3.1B)
Human Longevity
(2013, United States, $330M)
Qiagen
(1984, Germany)
PacBio
(2004, United States, $342M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
Hexagon Bio (2017, United States)
$61.0M - Series B - Sep 2021
Immunitas The.. (2019, United States)
$58.0M - Series B - Aug 2021
CAMP4 (2018, United States)
$45.0M - Series B - Mar 2021
54gene (2019, Nigeria)
$25.0M - Series B - Sep 2021
SeqOne (2017, France)
$22.7M - Series A - Jan 2022
View all 14 Funding Rounds on Tracxn Platform

27. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Proteomics Drug Discovery Software
19
27
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$684M (▲210%)
11(▲10%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$1.8B
52
1
122
11
Life Sciences Tech (Illumina)
(# Cos: 4920 | $27.4B)
Research & Development (Medidata)
(# Cos: 3970 | $22.9B)
Drug Discovery (Exscientia)
(# Cos: 1197 | $12.2B)
Proteomics (Cyrus Biotechnology)
(# Cos: 122 | $1.8B)
Cyrus Biotechnology
(2014, United States, $29.3M)
Vividion Therapeutics
(2016, United States, $271M)
Biognosys
(2008, Switzerland, $9.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Eikon (2019, United States)
$518M - Series B - Jan 2022
Eikon (2019, United States)
$148M - Series A - May 2021
Seismic (2019, United States)
$101M - Series A - Feb 2022
Interline The.. (2020, United States)
$92.0M - Series C - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
Avilar (2020, United States)
$60.0M - Seed - Nov 2021
Cyrus Biotech.. (2014, United States)
$18.4M - Series B - Dec 2021
View all 11 Funding Rounds on Tracxn Platform

28. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
CinCor (2018, United States)
$143M - Series B - Oct 2021
TransThera Sciences (2016, China)
$100M - Series D - Jul 2021
Cellino (2017, United States)
$80.0M - Series A - Jan 2022
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Juventas Ther.. (2007, United States)
$64.2M - Series C - Oct 2021
TenSixteen (2020, United States)
$40.0M - Series A - Jan 2022
ARMGO Pharma (2004, United States)
$35.0M - Series B - Dec 2021
View all 19 Funding Rounds on Tracxn Platform
Diversified
20
28
Back to index
Cardiac and Vascular Disorders (Withings)
(# Cos: 2599 | $31.0B)
Drugs (Moderna)
(# Cos: 344 | $10.5B)
Diversified (Tenaya Therapeutics)
(# Cos: 265 | $6.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$678M (▲30.7%)
19( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
44
$6.0B
207
45
265
18
Tenaya Therapeutics
(2016, United States, $248M)
Esperion Therapeutics
(1998, United States, $130M)
Portola Pharma
(2003, United States, $296M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

29. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomics Drug Discovery Software
21
29
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$621M (▲124%)
8(▼11.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$1.7B
44
2
103
10
Life Sciences Tech (Illumina)
(# Cos: 4920 | $27.4B)
Research & Development (Medidata)
(# Cos: 3970 | $22.9B)
Drug Discovery (Exscientia)
(# Cos: 1197 | $12.2B)
Genomics (Human Longevity)
(# Cos: 730 | $5.1B)
Drug Development (DNAnexus)
(# Cos: 103 | $1.7B)
DNAnexus
(2009, United States, $473M)
Insilico
(2014, China, $310M)
Arrakis Therapeutics
(2015, United States, $113M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Insilico (2014, China)
$255M - Series C - Jun 2021
DNAnexus (2009, United States)
$200M - Series G - Mar 2022
Expansion The.. (2016, United States)
$80.0M - Series B - Sep 2021
Lifebit (2017, United Kingdom)
$60.0M - Series B - Sep 2021
Deargen (2016, South Korea)
$17.0M - Series B - Feb 2022
Nostos Genomics (2018, Germany)
$5.6M - Seed - Feb 2022
PhenoTips (2012, Canada)
$2.0M - Seed - Sep 2021
View all 8 Funding Rounds on Tracxn Platform

30. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
COVID-19 Drugs
22
30
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$617M (▲215%)
12(▲20%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$1.1B
44
8
80
10
Infectious Diseases (Emergent BioSolutions)
(# Cos: 1988 | $27.8B)
Drugs (Roche)
(# Cos: 1080 | $22.2B)
Viral (Moderna)
(# Cos: 490 | $12.1B)
COVID-19 (GigaGen)
(# Cos: 80 | $1.1B)
GigaGen
(2011, United States, $36.1M)
Adagio
(2020, United States, $466M)
NantKwest
(2002, United States, $147M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Adagio (2020, United States)
$336M - Series C - Apr 2021
Nano (2003, United States)
$90.0M - Series C - Mar 2021
Touchlight (2008, United Kingdom)
$58.4M - Series B - Mar 2021
Apogenix (2005, Germany)
$29.4M - Series B - Dec 2021
Vaxxinity (2019, United States)
$27.0M - Series B - Mar 2021
Ethris (2009, Germany)
$26.3M - Series B - Feb 2022
ExeVir Bio (2020, Belgium)
$22.7M - Series A - Mar 2021
View all 12 Funding Rounds on Tracxn Platform

31. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Apollo Thera.. (2007, United Kingdom)
$145M - Series A - Jun 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Septerna (2020, United States)
$100M - Series A - Jan 2022
Evommune (2020, United States)
$83.0M - Series A - Sep 2021
Aristea Thera.. (2018, United States)
$63.0M - Series B - Jul 2021
Sparrow Pharm.. (2013, United States)
$50.0M - Series A - May 2021
Mestag Thera.. (2020, United Kingdom)
$34.0M - Seed - Aug 2021
View all 14 Funding Rounds on Tracxn Platform
Inflammatory Diseases Drugs
23
31
Back to index
Immunology (Moderna)
(# Cos: 905 | $23.4B)
Drugs (Biogen)
(# Cos: 763 | $22.5B)
Inflammatory Diseases (Nimbus
Therapeutics)
(# Cos: 236 | $4.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$610M (▼3.4%)
14(▼46.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
21
$4.1B
172
25
236
27
Nimbus Therapeutics
(2009, United States, $242M)
Second Genome
(2009, United States, $63.7M)
Karyopharm
(2008, United States, $207M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

32. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Clinical Trial Patient Recruitment
Platforms
24
32
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$595M (▲301%)
10(▼16.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
12
$1.2B
74
-
215
12
Life Sciences Tech (Exscientia)
(# Cos: 4920 | $27.4B)
Research & Development (Illumina)
(# Cos: 3970 | $22.9B)
Clinical Trials (Medidata)
(# Cos: 961 | $4.0B)
Scientific Sourcing (PatientsLikeMe)
(# Cos: 251 | $1.4B)
Patients (Evidation)
(# Cos: 215 | $1.2B)
Evidation
(2012, United States, $259M)
PatientsLikeMe
(2004, United States, $151M)
TrialSpark
(2014, United States, $250M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Reify Health (2012, United States)
$220M - Series C - Aug 2021
TrialSpark (2014, United States)
$156M - Series C - Sep 2021
Evidation (2012, United States)
$153M - Series E - Mar 2021
Antidote (2008, United Kingdom)
$23.2M - Series C - Jun 2021
TrialJectory (2017, United States)
$20.0M - Series A - Feb 2022
Mendel Health (2016, United States)
$18.0M - Series A - Jun 2021
BEKHealth (2016, United States)
$4.6M - Series A - Jun 2021
View all 10 Funding Rounds on Tracxn Platform

33. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Diabetes Drugs
25
33
Back to index
Diabetes (Dexcom)
(# Cos: 903 | $9.1B)
Drugs (Pendulum)
(# Cos: 243 | $5.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$553M (▲23.5%)
16(▼46.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$5.0B
168
24
243
27
Pendulum
(2012, United States, $57.0M)
Semma Therapeutics
(2015, United States, $158M)
Ocugen
(2013, United States, $18.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Kriya Therape.. (2012, United States)
$100M - Series B - Jul 2021
Cellino (2017, United States)
$80.0M - Series A - Jan 2022
ViaCyte (1999, United States)
$53.9M - Series D - Apr 2021
Elevian (2017, United States)
$40.0M - Series A - Sep 2021
MingSight (2009, United States)
$20.0M - Series A - Nov 2021
View all 16 Funding Rounds on Tracxn Platform

34. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Pivot Bio (2010, United States)
$430M - Series D - Jul 2021
Antheia (2013, United States)
$73.0M - Series B - Jul 2021
Tavotek (2018, United States)
$35.0M - Series B - Nov 2021
OriCiro Genomics (2018, Japan)
$7.3M - Series B - Jul 2021
Embion Technolo.. (2016, Switzerland)
$4.9M - Series A - Dec 2021
Jiaxing Xinbei Lai Bi.. (2017, China)
$1.5M - Seed - Sep 2021
CC Bio (2018, United Kingdom)
$1.2M - Seed - Aug 2021
View all 9 Funding Rounds on Tracxn Platform
Synthetic Biology
26
34
Back to index
Genomics (23andMe)
(# Cos: 7650 | $83.7B)
Applied Genomics (MyHeritage)
(# Cos: 4162 | $54.5B)
Synthetic Biology (Ginkgo Bioworks)
(# Cos: 68 | $3.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$553M (▲99.5%)
9(▼18.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$3.4B
54
3
68
13
Ginkgo Bioworks
(2009, United States, $796M)
Amyris
(2003, United States, $487M)
Synlogic Therapeutics
(2013, United States, $34.4M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

35. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
DNA Liquid Biopsy Diagnostics
27
35
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$551M (▼47.1%)
14(▲7.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$4.6B
62
6
97
11
Genomics (Ginkgo Bioworks)
(# Cos: 7650 | $83.7B)
Applied Genomics (MyHeritage)
(# Cos: 4162 | $54.5B)
Clinical Genomics (Invitae)
(# Cos: 2224 | $40.9B)
Diagnostics (Adaptive Biotechnologies)
(# Cos: 1631 | $27.1B)
Sequencing-based (Natera)
(# Cos: 1328 | $25.1B)
Liquid Biopsy (GRAIL)
(# Cos: 252 | $5.8B)
DNA (Guardant Health)
(# Cos: 97 | $4.6B)
Guardant Health
(2012, United States, $558M)
GRAIL
(2016, United States, $2.0B)
Inivata
(2014, United Kingdom, $164M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Scipher Medic.. (2014, United States)
$110M - Series D - Feb 2022
C2i Genomics (2019, United States)
$100M - Series B - Apr 2021
Scipher Medic.. (2014, United States)
$82.0M - Series C - Mar 2021
Nucleix (2008, Israel)
$55.0M - Series C - Apr 2021
Nucleix (2008, Israel)
$22.0M - Series C - Jan 2022
Gene Solutions (2018, Vietnam)
$15.0M - Series B - Oct 2021
View all 14 Funding Rounds on Tracxn Platform

36. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Sequencing Equipment
28
36
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$504M (▲70.3%)
11(▲22.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$3.3B
65
7
92
11
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9829 | $52.2B)
Instruments (Zeiss)
(# Cos: 2046 | $12.2B)
Genomics (Nanopore)
(# Cos: 229 | $4.7B)
Nucleic Acid Sequencing (Illumina)
(# Cos: 92 | $3.3B)
Illumina
(1998, United States, $28.0M)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series B - Jun 2021
Depixus (2012, France)
$34.5M - Series A - Dec 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
QuantuMDx (2008, United Kingdom)
$15.2M - Series C - Mar 2021
View all 11 Funding Rounds on Tracxn Platform

37. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Delivery Platforms
29
37
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$452M (▲114%)
11( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
14
$2.1B
76
8
111
8
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Enabling Technologies (Illumina)
(# Cos: 1680 | $17.0B)
Technology Platforms (Twist Bioscience)
(# Cos: 358 | $8.1B)
Gene Delivery (Synthego)
(# Cos: 111 | $2.1B)
Synthego
(2012, United States, $460M)
Beam Therapeutics
(2017, United States, $222M)
Recombinetics
(2008, United States, $67.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Synthego (2012, United States)
$200M - Series E - Feb 2022
Cambridge Ep.. (2012, United Kingdom)
$88.0M - Series D - Nov 2021
StrideBio (2015, United States)
$81.5M - Series B - Mar 2021
Genedit (2016, United States)
$26.0M - Series A - Sep 2021
Mekonos (2016, United States)
$25.0M - Series A - Nov 2021
Chameleon Bio.. (2017, United States)
$11.1M - Seed - Mar 2021
Bendao Gene Technology (2018, China)
$9.2M - Series A - Apr 2021
View all 11 Funding Rounds on Tracxn Platform

38. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Inari (2016, United States)
$208M - Series D - May 2021
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
Equinom (2012, Israel)
$20.0M - Series C - Jun 2021
Biome Makers (2015, United States)
$15.0M - Series B - Aug 2021
Meiogenix (2010, France)
$13.0M - Series A - Dec 2021
Phylos Biosci.. (2014, United States)
$12.2M - Series C - Apr 2021
CoverCress (2013, United States)
$8.0M - Series B - Mar 2021
View all 19 Funding Rounds on Tracxn Platform
Agrigenomics
30
38
Back to index
Genomics (Ginkgo Bioworks)
(# Cos: 7650 | $83.7B)
Applied Genomics (MyHeritage)
(# Cos: 4162 | $54.5B)
Agrigenomics (Limagrain)
(# Cos: 301 | $4.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$448M (▼12.1%)
19(▼5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
35
$4.5B
140
17
301
25
Limagrain
(1965, France, $200M)
Pioneer
(1935, United States, $1.7B)
Arcadia Biosciences
(2002, United States, $101M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

39. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Kallyope (2014, United States)
$236M - Series D - Feb 2022
Verge Genomics (2015, United States)
$98.0M - Series B - Dec 2021
Alchemab (2019, United Kingdom)
$82.7M - Series A - Apr 2021
Bluepha (2014, China)
$66.4M - Series B - Aug 2021
Clear Labs (2014, United States)
$60.0M - Series C - May 2021
Lifebit (2017, United Kingdom)
$60.0M - Series B - Sep 2021
Tavotek (2018, United States)
$35.0M - Series B - Nov 2021
View all 27 Funding Rounds on Tracxn Platform
Genomics Research Services
31
39
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9829 | $52.2B)
Research Services (Ginkgo Bioworks)
(# Cos: 5007 | $30.6B)
Genomics (Ancestry)
(# Cos: 825 | $2.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$426M (▲11.4%)
27(▼12.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
59
$2.7B
242
20
825
28
Ancestry
(1996, United States, $146M)
Personalis
(2011, United States, $87.3M)
Caribou Biosciences
(2011, United States, $157M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

40. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Vedere (2019, United States)
$77.0M - Series A - May 2021
EyeBio (2021, United Kingdom)
$65.0M - Series A - Feb 2022
Wuhan Newfoss Biotech.. (2008, China)
$63.0M - Series C - Nov 2021
LENZ Therapeu.. (2021, United States)
$47.0M - Series A - Jun 2021
Sydnexis (2014, United States)
$45.0M - Series B - Aug 2021
Phanes Therap.. (2016, United States)
$40.0M - Series B - May 2021
Coave Therapeutics (2021, France)
$25.1M - Series B - Jul 2021
View all 16 Funding Rounds on Tracxn Platform
Retinal Disorders Drugs
32
40
Back to index
Ophthalmology (Zeiss)
(# Cos: 1005 | $11.8B)
Drugs (Gyroscope)
(# Cos: 337 | $6.8B)
Retinal Disorders (CureVac)
(# Cos: 70 | $2.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$425M (▼53.7%)
16(▼5.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$2.2B
48
8
70
11
CureVac
(2000, Germany, $975M)
Rezolute
(2012, United States)
Molecular Partners
(2004, Switzerland, $59.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

41. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Decentralized Clinical Trial Management
33
41
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$418M (▲215%)
4(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
-
$560M
4
-
8
3
Life Sciences Tech (Exscientia)
(# Cos: 4920 | $27.4B)
Research & Development (Illumina)
(# Cos: 3970 | $22.9B)
Clinical Trials (Medidata)
(# Cos: 961 | $4.0B)
Study Implementation (4G Clinical)
(# Cos: 493 | $1.9B)
CTMS and EDC (Florence)
(# Cos: 456 | $1.5B)
CTMS (Clinical Ink)
(# Cos: 278 | $1.0B)
Decentralized Clinical Trials
(Medable)
(# Cos: 8 | $560M)
Medable
(2012, United States, $521M)
Curebase
(2017, United States, $19.0M)
Hawthorne Effect
(2015, United States, $20.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Medable (2012, United States)
$304M - Series D - Oct 2021
Medable (2012, United States)
$78.0M - Series C - Apr 2021
Hawthorne Eff.. (2015, United States)
$20.0M - Series A - Jun 2021
Curebase (2017, United States)
$16.4M - Series A - May 2021

42. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cancer Precision Medicine Diagnostic
Tests
34
42
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$418M (▲1234%)
14(▲55.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$796M
37
2
57
9
Oncology (Exscientia)
(# Cos: 4569 | $103B)
In-Vitro Diagnostic Tests (Natera)
(# Cos: 1150 | $18.8B)
Diversified (Guardant Health)
(# Cos: 512 | $9.5B)
Precision Medicine (Personalis)
(# Cos: 57 | $796M)
Personalis
(2011, United States, $87.3M)
PierianDx
(2014, United States, $69.3M)
OncoDNA
(2012, Belgium, $37.4M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
ITM (2004, Germany)
$109M - Series D - Apr 2021
Strata Oncology (2015, United States)
$90.0M - Series C - Jul 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
ITM (2004, Germany)
$30.5M - Series D - Jun 2021
PierianDx (2014, United States)
$30.0M - Series C - Nov 2021
ITM (2004, Germany)
$28.0M - Series D - Feb 2022
Xcell Bioscie.. (2012, United States)
$27.5M - Series B - Jan 2022
View all 14 Funding Rounds on Tracxn Platform

43. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ophthalmology Drugs
35
43
Back to index
Ophthalmology (Zeiss)
(# Cos: 1005 | $11.8B)
Drugs (Gyroscope)
(# Cos: 337 | $6.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$398M (▲95%)
33( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
37
$6.8B
237
45
337
43
Gyroscope
(2016, United Kingdom, $255M)
CureVac
(2000, Germany, $975M)
Ocugen
(2013, United States, $18.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Vedere (2019, United States)
$77.0M - Series A - May 2021
INTERGALACTIC.. (2020, United States)
$75.0M - Series A - Oct 2021
EyeBio (2021, United Kingdom)
$65.0M - Series A - Feb 2022
Wuhan Newfoss Biotech.. (2008, China)
$63.0M - Series C - Nov 2021
Oculis (2003, Switzerland)
$57.0M - Series C - May 2021
LENZ Therapeu.. (2021, United States)
$47.0M - Series A - Jun 2021
View all 33 Funding Rounds on Tracxn Platform

44. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
SHINE Medical.. (2010, United States)
$150M - Series C - Jun 2021
ITM (2004, Germany)
$109M - Series D - Apr 2021
APRINOIA (2015, Taiwan)
$40.0M - Series C - Dec 2021
ITM (2004, Germany)
$30.5M - Series D - Jun 2021
ITM (2004, Germany)
$28.0M - Series D - Feb 2022
ImaginAb (2007, United States)
$12.8M - Series C - Jun 2021
Swiss Nuclides (2017, Switzerland)
$2.8M - Seed - Jun 2021
View all 8 Funding Rounds on Tracxn Platform
Radioisotopes for Imaging
36
44
Back to index
Imaging Diagnostics (Butterfly Network)
(# Cos: 689 | $6.3B)
Accessories (Acusphere)
(# Cos: 130 | $1.6B)
Radioisotopes (Advanced Accelerator
Applications)
(# Cos: 80 | $1.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$374M (▲218%)
8(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
12
$1.5B
52
11
80
6
Advanced Accelerator A..
(2002, France, $56.1M)
Acusphere
(1993, United States, $35.0M)
TauRx
(2002, Singapore, $315M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

45. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
RNA Interference Platforms
37
45
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$362M (▼52.8%)
4(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
5
$1.9B
37
8
56
7
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Enabling Technologies (Illumina)
(# Cos: 1680 | $17.0B)
Technology Platforms (Twist Bioscience)
(# Cos: 358 | $8.1B)
RNA interference (CureVac)
(# Cos: 56 | $1.9B)
CureVac
(2000, Germany, $975M)
Dicerna Pharmaceuticals
(2007, United States, $107M)
Expansion Therapeutics
(2016, United States, $140M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
Expansion The.. (2016, United States)
$80.0M - Series B - Sep 2021
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Envisagenics (2013, United States)
$19.2M - Series A - Sep 2021

46. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
HilleVax (2021, United States)
$135M - Series D - Sep 2021
Icosavax (2017, United States)
$100M - Series B - Apr 2021
Pulmocide (2013, United Kingdom)
$92.0M - Series C - May 2021
Cargene Therapeut.. (2020, Singapore)
$19.2M - Seed - Dec 2021
Pulmotect (2007, United States)
$3.5M - Series A - Mar 2021
Pulmocide (2013, United Kingdom)
$3.5M - Series C - Dec 2021
Pulmotect (2007, United States)
$2.2M - Series A - Feb 2022
View all 8 Funding Rounds on Tracxn Platform
Lung Infection Drugs
38
46
Back to index
Pulmonology (Mallinckrodt Pharmaceuticals)
(# Cos: 655 | $8.1B)
Drugs (ASLAN Pharmaceuticals)
(# Cos: 193 | $4.9B)
Lung Infections (Icosavax)
(# Cos: 21 | $641M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$355M (▲328%)
8(▲60%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$641M
15
2
21
5
Icosavax
(2017, United States, $152M)
ReViral
(2011, United Kingdom, $121M)
Pulmocide
(2013, United Kingdom, $153M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

47. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Metabolic Disorders Drugs
39
47
Back to index
Metabolic Diseases (Sigilon)
(# Cos: 426 | $10.8B)
Drugs (MannKind Corp)
(# Cos: 296 | $9.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$351M (▲71.3%)
26(▼31.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
33
$9.4B
239
62
296
40
MannKind Corp
(1991, United States, $50.0M)
Sigilon
(2015, United States, $195M)
Nimbus Therapeutics
(2009, United States, $242M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Ceptur Therap.. (2021, United States)
$75.0M - Series A - Jan 2022
Sciwind (2017, China)
$70.0M - Series C - Oct 2021
Alebund (2018, China)
$60.0M - Series B - May 2021
View all 26 Funding Rounds on Tracxn Platform

48. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Life Science R&D Workflow
Management Software
40
48
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$335M (▲254%)
8(▲100%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$556M
18
-
51
4
Life Sciences Tech (Illumina)
(# Cos: 4920 | $27.4B)
Research & Development (Medidata)
(# Cos: 3970 | $22.9B)
Drug Informatics (NantHealth)
(# Cos: 779 | $4.6B)
R&D Workflow Management
(Benchling)
(# Cos: 51 | $556M)
Benchling
(2012, United States, $412M)
Curoverse
(2010, United States, $1.7M)
Standigm
(2015, South Korea, $68.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Benchling (2012, United States)
$200M - Series E - Apr 2021
Benchling (2012, United States)
$100M - Series F - Nov 2021
Code Ocean (2014, United States)
$15.0M - Series A - May 2021
Intelligencia (2018, United States)
$13.8M - Series A - Aug 2021
Standigm (2015, South Korea)
$10.0M - Series C - Jul 2021
Catalytic DS (2010, United States)
$5.8M - Series A - Jun 2021
Seqera Labs (2018, Spain)
$5.5M - Seed - Sep 2021
View all 8 Funding Rounds on Tracxn Platform

49. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
DNAnexus (2009, United States)
$200M - Series G - Mar 2022
Immunitas The.. (2019, United States)
$58.0M - Series B - Aug 2021
CAMP4 (2018, United States)
$45.0M - Series B - Mar 2021
Seven Bridges.. (2009, United States)
$15.0M - Series C - Apr 2021
Geneyx (2018, Israel)
$6.5M - Seed - Nov 2021
My Intelligent Machi.. (2016, Canada)
$5.0M - Seed - Apr 2021
AarogyaAI (2019, India)
$700K - Seed - Jan 2022
View all 9 Funding Rounds on Tracxn Platform
Genome Sequence Analysis Software
41
49
Back to index
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Genome Informatics (Human Longevity)
(# Cos: 737 | $5.0B)
Sequence Analysis (DNAnexus)
(# Cos: 264 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$330M (▲119%)
9(▼18.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
24
$1.2B
89
2
264
11
DNAnexus
(2009, United States, $473M)
Scailyte
(2017, Switzerland, $6.0M)
Immunitas Therapeutics
(2019, United States, $97.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

50. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Intravenous Drug Delivery Systems
42
50
Back to index
Drug Delivery (Acorda)
(# Cos: 858 | $8.0B)
Intravenous (Insulet)
(# Cos: 78 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$326M (▲1865%)
7( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
9
$1.2B
48
13
78
7
Insulet
(2000, United States, $120M)
Xeris Pharma
(2005, United States, $155M)
Lyra Therapeutics
(2005, United States, $53.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Enable Inject.. (2010, United States)
$215M - Series C - Jan 2022
Shasqi (2015, United States)
$50.0M - Series B - Nov 2021
Credence MedS.. (2011, United States)
$39.9M - Series D - Sep 2021
PharmaJet (2005, United States)
$15.4M - Series B - Apr 2021
AscentX Medical (2008, United States)
$3.0M - Series A - Apr 2021
Sixfold Bios.. (2017, United Kingdom)
$2.2M - Seed - Dec 2021
NanOptima (2016, United Kingdom)
Undisclosed - Seed - Mar 2021

51. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Chemoproteomics Software
43
51
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$301M (▲349%)
6(▲500%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
-
$368M
7
-
12
3
Life Sciences Tech (Illumina)
(# Cos: 4920 | $27.4B)
Research & Development (Medidata)
(# Cos: 3970 | $22.9B)
Drug Discovery (Exscientia)
(# Cos: 1197 | $12.2B)
Proteomics (Cyrus Biotechnology)
(# Cos: 122 | $1.8B)
Chemoproteomics (Frontier Medicines)
(# Cos: 12 | $368M)
Frontier Medicines
(2018, United States, $156M)
Seismic
(2019, United States, $101M)
Interline Therapeutics
(2020, United States, $92.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Seismic (2019, United States)
$101M - Series A - Feb 2022
Interline The.. (2020, United States)
$92.0M - Series C - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
AI Proteins (2021, United States)
$11.3M - Series B - Jan 2022
Protai (2021, Israel)
$8.0M - Seed - Jan 2022
Abterra Biosc.. (2009, United States)
$200K - Seed - May 2021

52. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ceptur Therap.. (2021, United States)
$75.0M - Series A - Jan 2022
Alebund (2018, China)
$60.0M - Series B - May 2021
Alebund (2018, China)
$54.5M - Series B - Sep 2021
Hangzhou Andao Pharma.. (2014,
China)
$50.0M - Series B - Dec 2021
Renibus Thera.. (2013, United States)
$34.6M - Series A - Feb 2022
Wuhan Metwell Biotech.. (2015, China)
$15.5M - Series A - Sep 2021
Oncorena (2011, Sweden)
$7.2M - Series A - Dec 2021
View all 9 Funding Rounds on Tracxn Platform
Renal Disorders Drugs
44
52
Back to index
Metabolic Diseases (Sigilon)
(# Cos: 426 | $10.8B)
Drugs (MannKind Corp)
(# Cos: 296 | $9.4B)
Renal Disorders (Allena)
(# Cos: 78 | $2.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$300M (▲125%)
9(▼18.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$2.2B
65
14
78
11
Allena
(2011, United States, $96.0M)
Altimmune
(1997, United States, $58.0M)
Akebia Therapeutics
(2007, United States, $91.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

53. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Wound Healing Drugs
45
53
Back to index
Wound Care (Imbed Biosciences)
(# Cos: 543 | $2.0B)
Drugs (Adocia)
(# Cos: 189 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$299M (▲82.3%)
9(▼25%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$1.2B
126
22
189
11
Adocia
(2005, France, $37.3M)
Derma Sciences
(1984, United States, $18.2M)
Ilya Pharma
(2016, Sweden, $4.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Endeavor Biom.. (2018, United States)
$101M - Series B - Feb 2022
QBiotics (2000, Australia)
$64.4M - Series C - Jun 2021
CytoKi Pharma (2019, Denmark)
$45.0M - Series A - May 2021
TargED (2020, Netherlands)
$44.2M - Series A - Feb 2022
FirstString R.. (2006, United States)
$26.7M - Series B - Jun 2021
Stemson Thera.. (2019, United States)
$15.0M - Series A - Jul 2021
Biotherapy S.. (2013, United Kingdom)
$2.1M - Series A - Jul 2021
View all 9 Funding Rounds on Tracxn Platform

54. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ultrasound Imaging Devices
46
54
Back to index
Imaging Diagnostics (Siemens Healthineers)
(# Cos: 689 | $6.3B)
Ultrasound (Butterfly Network)
(# Cos: 117 | $1.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$286M (▲89.4%)
5(▼16.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$1.7B
50
6
117
9
Butterfly Network
(2011, United States, $350M)
INSIGHTEC
(1999, Israel, $487M)
SuperSonic Imagine
(2005, France, $81.6M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Exo (2015, United States)
$220M - Series C - Jul 2021
EchoNous (2015, United States)
$60.0M - Series C - Jun 2021
Pulsify Medical (2019, Belgium)
$4.5M - Series A - May 2021
MAUI Imaging (2006, United States)
$1.5M - Series B - Mar 2021
Focus & Fusion (2014, China)
Undisclosed - Series B - May 2021

55. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
At-Home Preventive Genetic Test Kits
47
55
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$284M (▼34.4%)
10(▲25%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$1.5B
55
2
236
8
Genomics (23andMe)
(# Cos: 7650 | $83.7B)
Applied Genomics (Ginkgo Bioworks)
(# Cos: 4162 | $54.5B)
Consumer Genomics (MyHeritage)
(# Cos: 851 | $3.7B)
Proactive Healthcare (Everlywell)
(# Cos: 236 | $1.5B)
Everlywell
(2015, United States, $330M)
Color
(2013, United States, $491M)
Viome
(2016, United States, $125M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Variant Bio (2018, United States)
$105M - Series B - Nov 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Viome (2016, United States)
$54.0M - Series B - Nov 2021
Recuro Health (2021, United States)
$15.0M - Series A - Aug 2021
Digbi Health (2018, United States)
$5.4M - Series A - Mar 2021
Orchid (2019, Australia)
$4.5M - Seed - Apr 2021
Dive Health (2019, United States)
$125K - Seed - Sep 2021
View all 10 Funding Rounds on Tracxn Platform

56. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Dermavant (2016, United States)
$160M - Series D - Jun 2021
CytoKi Pharma (2019, Denmark)
$45.0M - Series A - May 2021
Pyramid Bio (2015, United States)
$33.5M - Series C - Oct 2021
Aneira Pharma (2019, United States)
$25.0M - Series B - Apr 2021
Cytovation (2001, Norway)
$20.0M - Series A - Jan 2022
Omeza (2005, United States)
$5.0M - Series A - Mar 2021
CytoKi Pharma (2019, Denmark)
$19.2K - Seed - Apr 2021
Aesthetic Medicines
48
56
Back to index
Dermatology (Miramar Labs)
(# Cos: 878 | $7.5B)
Drugs (Incyte)
(# Cos: 332 | $6.0B)
Aesthetics (Revance Therapeutics)
(# Cos: 243 | $3.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$284M (▲298%)
7(▼30%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
44
$3.9B
175
30
243
14
Revance Therapeutics
(2002, United States, $191M)
Sienna Biopharmaceutic..
(2016, United States, $133M)
Castle Creek Pharma
(2015, United States, $663M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

57. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Synthesis Instruments
49
57
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$284M (▲140%)
5(▲25%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$482M
14
1
28
4
Genomics (MyHeritage)
(# Cos: 7650 | $83.7B)
Enabling Technologies (Illumina)
(# Cos: 1680 | $17.0B)
Instrument Systems (Nanopore)
(# Cos: 317 | $5.4B)
Nucleic Acid Synthesis (DNA
Script)
(# Cos: 28 | $482M)
DNA Script
(2014, France, $280M)
Nuclera Nucleics
(2013, United Kingdom, $54.5M)
Molecular Assemblies
(2013, United States, $52.7M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
DNA Script (2014, France)
$200M - Series C - Oct 2021
Nuclera Nucl.. (2013, United Kingdom)
$42.5M - Series B - Feb 2022
Molecular Ass.. (2013, United States)
$24.0M - Series A - Apr 2021
Molecular Ass.. (2013, United States)
$10.0M - Series A - Nov 2021
Switchback Sy.. (2019, United States)
$7.0M - Series A - Oct 2021

58. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nanoparticle Based Drug Delivery
Systems
50
58
Back to index
Drug Delivery (Insulet)
(# Cos: 858 | $8.0B)
Nanoparticle Based (Acorda)
(# Cos: 317 | $1.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$281M (▲56.2%)
12(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$1.4B
175
19
317
12
Acorda
(1995, United States, $66.5M)
Precision Nanosystems
(2010, Canada, $25.4M)
Genedit
(2016, United States, $34.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
Genedit (2016, United States)
$26.0M - Series A - Sep 2021
Topas Therapeutics (2016, Germany)
$21.3M - Series B - Jul 2021
RS Research (2015, Turkey)
$12.0M - Series A - Dec 2021
Clene Nanomed.. (2012, United States)
$9.3M - Series D - May 2021
NanoSyrinx (2018, United Kingdom)
$8.5M - Seed - Jul 2021
Ascendia Phar.. (2012, United States)
$5.0M - Series A - Apr 2021
View all 12 Funding Rounds on Tracxn Platform

59. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Recent funding rounds
Investment Trends
Most Active Investors
Top Funded Business Models
Explore more on Tracxn
All Tech Companies
US Tech Companies
Online Travel Companies
Companies using AI in Healthcare
Companies founded by Stanford GSB Alumni
Soonicorn club in Fintech
Analyst Picks in Israel Tech
Key News in FinTech
Events in Bay Area
Angel Investors in United States
Bluebox
Companies Investment Activity
Miscellaneous
Company Detail Page of DoorDash
Competitors of Freshworks
Cap Table for TransferWise
Financials for Ola
Employee Count for Revolut
Company Due Diligence Exits
Public Companies
Acquired Companies
Most Active Acquirers
Reports
Delhivery - Company Report
Novel Foods - Business Model Report
HRTech - Feed Report
FinTech - Top Business Models Report
US Tech - Top Business Models Report
US Tech - Monthly Report
59

60. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Explore other Reports on Tracxn
HRTech
InsurTech
Food Tech
Novel Foods
Blockchain Network
P2P Remittance
Business Model Reports
FinTech Europe
Consumer Digital SEA
HiTech US
Feed Geo Reports
Company Reports
Monthly Unicorn Report
Unicorn Reports
Transferwise
Coursera
BigBasket
Feed Reports Top Business Models in PA
FinTech
Enterprise Applications
Artificial Intelligence
Geo Monthly Reports
US Tech
Europe Tech
China Tech
Top Business Models in Geo
India Tech
Israel Tech
UK & Ireland Tech
60

61. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Thank You
61
Any and all information either accessed from the website www.tracxn.com or having otherwise originated from Tracxn Technologies Limited including but not limited to the information
contained herein ("Data") is the sole property of Tracxn Technologies Limited (hereinafter "Tracxn"). You shall not recirculate, distribute, transmit, publish, or sell the Data or any portion
thereof in any form or by any means, either for commercial or non-commercial use, or permit any third party to use or distribute the Data or any portion thereof; to any other party, except
with the prior written consent of Tracxn. You may however incorporate insubstantial portions, extracts, abstracts or summaries from the Data into analysis, presentations or tools for your
customers or for your internal use, so long as Tracxn is clearly and visibly identified as the source of information.
For further information please refer to our Terms of Use at www.tracxn.com